A novel AβPP mutation exclusively associated with cerebral amyloid angiopathy

Annals of Neurology

Volumn 58, Issue 4, 2005, Pages 639-644

  Obici, Laura ^a   Demarchi, Andrea ^b   De Rosa, Giulia ^c   Bellotti, Vittorio ^a,d   Marciano, Sabrina ^a   Donadei, Simona ^a   Arbustini, Eloisa ^a   Palladini, Giovanni ^a   Diegoli, Marta ^a,d   Genovese, Egidio ^e   Ferrari, Giancarlo ^c   Coverlizza, Sergio ^b   Merlini, Giampaolo ^a,d  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c Ospedale di Ivrea   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e Clinica Eporediese   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMYLOID; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ASPARAGINE; ASPARTIC ACID; GLUTAMIC ACID; GLUTAMINE; GLYCINE; LYSINE; LEUCINE; VALINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BIOACCUMULATION; BRAIN HEMORRHAGE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; DNA DETERMINATION; DNA SEQUENCE; FEMALE; GENE MUTATION; GENE SEQUENCE; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MUTATIONAL ANALYSIS; NEUROFIBRILLARY TANGLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PEDIGREE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; SEQUENCE ANALYSIS; TISSUE SECTION; VASCULAR AMYLOIDOSIS; BRAIN; COMPARATIVE STUDY; FAMILY HEALTH; GENETICS; METABOLISM; METHODOLOGY; MUTATION; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PATHOLOGY;

AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; BLOTTING, NORTHERN; BRAIN; CEREBRAL AMYLOID ANGIOPATHY, FAMILIAL; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; HUMANS; LEUCINE; MUTATION; NEUROFIBRILLARY TANGLES; PEDIGREE; TOMOGRAPHY, X-RAY COMPUTED; VALINE;

EID: 25444432529     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20571     Document Type: Article

References (17)

1. Revesz T, Holton JL, Tammaryn L, et al. Sporadic and familial cerebral amyloid angiopathies. Brain Pathol 2002;12:343-357.
2. Rensink AAM, de Waal RMW, Kremer B, Verbeek MM. Pathogenesis of cerebral amyloid angiopathy. Brain Res Rev 2003;43:207-223.
3. Frangione B, Revesz, Vidal R, et al. Familial cerebral amyloid angiopathy related to stroke and dementia. Amyloid 2001;8 (suppl 1):36-42.
4. Natté R, Maat-Schieman MLC, Haan J, et al. Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles. Ann Neurol 2001;50:765-771.
5. Miravalle L, Tokuda T, Chiarle R, et al. Substitutions at codon 22 of Alzheimer's Aβ peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. J Biol Chem 2000;275:27110-27116.
6. Cras P, van Harskamp F, Hendriks L, et al. Presenile Alzheimer's dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala→Gly mutation. Acta Neuropathol 1998;96:253-260.
7. Nilsberth C, Westlind-Danielsson A, Eckman CB, et al. The "Arctic" APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation. Nat Neurosci 2001;4:887-893.
8. Grabowski TJ, Cho HS, Vonsattel JPG, et al. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 2001;49:697-705.
9. Greenberg SM, Shin Y, Grabowski TJ, et al. Hemorrhagic stroke associated with the Iowa amyloid precursor protein mutation Neurology 2003;60:1020-1022.
10. Obici L, Bellotti V, Mangione P, et al. The new apolipoprotein A-I valiant Leu174Ser causes hereditary cardiac amyloidosis and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide. Am J Pathol 1999;155:695-702.
11. Cazeneuve C, Ajrapetyan H, Papin S, et al. Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet 2000;67:1136-1143.
12. Nicoll JAR, Yamada M, Frackowiak J et al. Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA position statement. Neurobiol Aging 2004;25:589-597.
13. Van Nostrand WE, Melchor JP, Romanov G, et al. Pathogenic effects of cerebral amyloid angiopathy mutations in the amyloid β-protein precursor. Ann NY Acad Sci 2002;977:258-265.
14. Vinters HV, Natté R, Maat-Schieman MLC, et al. Secondary microvascular degeneration in amyloid angiopathy of patients with hereditary cerebral hemorrhage with amyloidosis Dutch type (HCHWA-D). Acta Neuropathol 1998;95:235-244.
15. Greenberg SM, Vonsattel JP, Segal AZ, et al. Association of apolipoprotein E epsilon 2 and vasculopathy in cerebral amyloid angiopathy. Neurology 1998;50:961-965.
16. Chid F, Stefani M, Taddei N, et al. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 2003;424:805-808.
17. Fernandez-Escamilla A, Rousseau F, Schymkowitz J, Serrano L. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotechnol 2004;22:1302-1306.